Design, synthesis, evaluation and optimization of novel azole analogues as potent antifungal agents

Bioorg Med Chem. 2024 Jan 1:97:117543. doi: 10.1016/j.bmc.2023.117543. Epub 2023 Dec 5.

Abstract

In order to develop antifungal drugs, a series of novel azole analogues were designed and synthesized based on our previous work. Most of the target compounds had broad-spectrum antifungal activity, which showed excellent to moderate inhibitory activity against the tested strains, except A. fum 0504656. Among these, compounds B3, B7, B8, B11, B12 and E9 showed excellent activity against C. alb Y0109 and C. alb SC5314 (with the MIC80: 0.0156 ug/mL). In addition, compound B3 showed the best inhibitory activity against fluconazole-resistant strains C. alb 901 and C. alb 904, and had low toxicity against NIH/3T3 cells at the effective MIC range against fungi. Structure-activity relationship and docking studies of the derivatives suggest that the presence of the 2-fluoro-4-hydroxyphenyl and 1,2,3-triazole group enhance the antifungal activity of the compounds, which may be related to the interaction of the key groups with the amino acids surrounding the target enzyme.

Keywords: Antifungal activity; Azole; CYP51; Docking; SARs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antifungal Agents* / chemistry
  • Azoles* / pharmacology
  • Candida albicans
  • Fluconazole / pharmacology
  • Mice
  • Microbial Sensitivity Tests
  • Structure-Activity Relationship

Substances

  • Antifungal Agents
  • Azoles
  • Fluconazole